Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,828
Total Claims
$869K
Drug Cost
1,192
Beneficiaries
$729
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+30%
Opioid rate vs peers
53.5% vs 41.3% avg
+83%
Cost per patient vs peers
$729 vs $399 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
53.5%
Opioid Rate
7,940
Opioid Claims
$449K
Opioid Cost
11.1%
Long-Acting Rate
This provider's opioid prescribing rate of 53.5% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 0 claims · $0
Generic: 14,191 claims · $439K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Hydrocodone/Acetaminophen | 4,423 | $150K |
| Buprenorphine | 238 | $97K |
| Buprenorphine Hcl | 46 | $41K |
| Linaclotide | 63 | $35K |
| Rimegepant Sulfate | 16 | $33K |
| Tapentadol Hcl | 11 | $25K |
| Oxycodone Hcl/Acetaminophen | 805 | $25K |
| Galcanezumab-Gnlm | 31 | $24K |
| Gabapentin Enacarbil | 24 | $24K |
| Oxycodone Myristate | 39 | $23K |
| Fentanyl | 134 | $20K |
| Lidocaine | 232 | $19K |
| Suvorexant | 41 | $18K |
| Gabapentin | 918 | $18K |
| Pregabalin | 648 | $17K |
Prescribing Profile
51
Unique Drugs
21.0
Anomaly Score
Patient Profile
70
Avg Age
67%
Female
2.05
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About